Evidence map›Paper›PMID 38137983›Full record

ArticleMicroorganisms2023

Prevalence of

Antonio Riccardo Buonomo, Giulio Viceconte, Ludovica Fusco, Marina Sarno, Isabella di Filippo, Luca Fanasca, Paola Salvatore, Ivan Gentile

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Antonio Riccardo BuonomoDepartment of Clinical Medicine and Surgery, University of Naples "Federico II", Via Sergio Pansini n.5, 8031 Naples, Italy.ORCID 0000-0002-4378-8366
Giulio ViceconteDepartment of Clinical Medicine and Surgery, University of Naples "Federico II", Via Sergio Pansini n.5, 8031 Naples, Italy.
Ludovica FuscoDepartment of Clinical Medicine and Surgery, University of Naples "Federico II", Via Sergio Pansini n.5, 8031 Naples, Italy.
Marina SarnoDepartment of Clinical Medicine and Surgery, University of Naples "Federico II", Via Sergio Pansini n.5, 8031 Naples, Italy.
Isabella di FilippoDepartment of Clinical Medicine and Surgery, University of Naples "Federico II", Via Sergio Pansini n.5, 8031 Naples, Italy.
Luca FanascaDepartment of Molecular Medicine and Medical Biotechnology, University of Naples "Federico II", 8031 Naples, Italy.
Paola SalvatoreDepartment of Molecular Medicine and Medical Biotechnology, University of Naples "Federico II", 8031 Naples, Italy.
Ivan GentileDepartment of Clinical Medicine and Surgery, University of Naples "Federico II", Via Sergio Pansini n.5, 8031 Naples, Italy.
University of Naples Federico II · IT

Funding

European Commission PNRR Extended Partnership initiative on Emerging Infectious Diseases (project no. PE00000007, INF-ACT)Gilead Sciences (Italy) Fellowship Program 2021
6 · The paper itself

Abstract

background

methodsAll patients over 18 years of age admitted to the Infectious Diseases Unit for SARS-CoV-2 pneumonia between July 2021 and December 2022 were included. Patients undergoing invasive mechanical ventilation or ECMO, those with risk factors for developing PJP, and those receiving prophylaxis for

resultsOf 290 screened patients, 59 (20%) met the inclusion criteria and were enrolled. Only 1 of 59 patients (1.7%) tested positive for

conclusionsOur results are in line with the previous findings of other studies that confirmed a very low prevalence of

Indexed as

COVID-19immunocompromisedPneumocystis jiroveciipneumoniaSARS-CoV-2

Identifiers

PMID38137983
PMCPMC10745747
OpenAlexW4388900640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.